An Update on Direct Oral Anticoagulation

Tags: Online learning, Medication therapy management

This course is part of our Professional Development Clinical Bundle, available for purchase with 2020 OPA Membership. For more information, click here!

According to recent Canadian data, while frequency of oral anticoagulation therapy has retained relatively stable warfarin use is decreasing and the use of Direct Oral Anticoagulants (DOACs) is increasing. Consequently, understanding the appropriate use of DOACs has become increasingly important. This program will review the most recent information on using DOACs in specific patient populations—such as managing venous thromboembolism (VTE) in patients with cancer or obesity—and the pharmacist’s role in monitoring and following-up with DOACs therapy.

Program Outline
This program consists of a one-hour online module, final exam and evaluation:

  • An Update on Oral Anticoagulation (1 hr)
  • Declaration of Completion of Online Module
  • Final Multiple-Choice Exam (0.25 hr)
  • Program Evaluation


Number of Continuing Education Units

Accreditation # 

Accreditation Expiry Date
November 29, 2020

Course Availability
This course must be completed one day before its expiry date; access will be removed.

Learning Format

  • Online, didactic learning module
  • Case study analysis and discussion

Learner Assessment
Multiple-choice assessment

How to Register: To register, please scroll to the bottom of the page and click on PROGRAM AND PRICING. A drop-down menu will provide pricing information for members and non-members*. Select the option that applies to you, then click on Add to Cart to start the registration process.

*Not a member? OPA members receive significant discounts on professional development. Find out about becoming a member here.

If you’re a pharmacist, you may be eligible for funding from the Allied Health Professional Development Fund (AHPDF). Click here for more information, and to apply.

Learning Objectives
Upon completion of this program, participants will be able to:

  • Summarize recent evidence for use of DOACs in practice
  • Describe considerations for the use of DOACs in specific patient populations
  • Identify tools to support the pharmacist’s role in ensuring optimal efficacy and safety of oral anticoagulant therapy

Program Completion
To receive a letter of completion for this program, participants must complete the following requirements before the day precedomg its expiry date: 

  • Complete the program’s online modules. Instructions will be emailed after registration.
  • Complete the multiple-choice exam, achieving a score of 70 per cent or higher within a maximum two attempts.
  • Complete a program evaluation.

Prerequisites and Target Audience
This program has no prerequisites. Pharmacists and pharmacy students would find this learning useful and applicable.

Subject Matter Experts

  • Natalie Crown, RPh, ACPR (BScPhm, PharmD)
  • Bill Bartle, RPh (BScPhm, PharmD)
  • Jonathan Hunchuck, RPh, ACPR (BScPhm, PharmD)

Last updated: November 29, 2019

Inquiries: Please contact OPA’s professional development team by phone at 416-441-0788, option 3 (toll-free in Ontario at 1-877-341-0788, option 3), or by email at

Cancellation Policy: Cancellation requests must be submitted in writing to no later than five days after access to the program has been emailed to you. A $10 (+HST) administration and processing fee will apply. Cancellations will not be permitted once log-in to access the program material has been initiated. Program registration fees will not be refunded after the cancellation deadline.

Protecting your privacy: Your privacy is important to us. Some information you provide in program registration forms and exercises may be considered personal information. OPA collects, uses, and shares the information contained in program registration forms and exercises to process your registration; issue certificates of completion; award continuing education credits; and deliver OPA services, programs, and publications to you.

Learners’ code of conduct: By registering for an OPA education program, you agree to follow OPA’s Learners’ Code of Conduct. For further details, click here

Event Date: Recurring | City: Online | Venue: Online

Pricing and Registration
Member Rate
An Update on Direct Oral Anticoagulants 2019   $20.00 Add to Cart 
Non-Member Rate
An Update on Direct Oral Anticoagulants 2019   $40.00 Add to Cart 
Back to top